sset EXT-C.10 – Website / 52 Pages — Category B Assets, in Z
Appendix EXT-C entry Asset EXT-C.10 – Website / 52 Pages — Category B Assets, in Z
http://pharmaceuticalintelligence.com
Asset EXT-C.10 Child’s: Password Protected Page
Website Diligence: 52 Page List, Hosting and Interactions Types
Identity
- Category B Assets. Title at T1. $0 on Chart 4. Dollars = Z.
- 52 Pages = one site.
- 4 = Portals EXT-C.9.8–9.11 (already on C-22 Part E). Same objects. One Z row, not two.
- 48 = remaining Pages + hosting + views/visitors.
- 757 Categories used here; priced in Class I.
- Class VIII = subscriber file only (Category A Assets). Views stay on EXT-C.10.
- Not Journal Posts. Not a second Chart 4.
- Full label only: EXT-C.10. Never “C.10” alone on a page your name is on.
What it is
The pharmaceuticalintelligence.com layer as a Category B asset:
- Website Name:
Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA
- [1] Website URL [2] Domain name on WordPress.com [3] Journal Name
pharmaceuticalintelligence.com
- Website architecture: 52 Parent Page with 555 Children Pages [607-52]
- Public discipline exhibited in Website Global reach as in Website Statistics
- Themes covered in Journal Ontology N=757
- parent/child map,
- the 52 Pages as high-signal structure around the corpus in the Journal
- Compute does not buy this page.
- Hosting is not a purchase order.
Status
- Asset EXT-C.10 and COM Part 23 = Category B. Schedule B = Yes. In one Z = Phase-2 fair value, with every other Yes asset.
- $0 on Chart 4.
- Chart 4 stays $650 M.
- Title at T1.
- Not a compute PO.
- Not exclusivity.
- Not a ROFR.
- Hosting is IE only.
- Beyond hosting: CTS / MI / IF / MP / SI / AE, See Child’s Page
| Type | Meaning |
|---|---|
| CTS | Primary training data or ontology for the MFMH |
| MI | Process, validation, curation, or design logic |
| IE | Compute, execution, hosting, or runtime |
| MP | Packaging, transfer readiness, or value capture |
| AE | Refresh or evolve after initial training |
| IF | Foundation / catalog; not a direct training signal |
| SI | Full-stack evaluation and orchestration |
- For Hosting and Interactions Type, See on the Child: Password Protected Page Website Diligence: 52 Page List, Hosting and Interactions Types
- Where the inventory and the column live
52 Pages inventory (Index):
TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
- COM Part 23, Board 4 has the column. This Parent has the asset. The JPEG and cell map are on the Asset EXT-C.10 Child’s Page and on COM Part 23 Page.
- Asset EXT-C.10 was launched as a column on COM Part 23 (9/17/2026).
COM 23 Parent (model), Board 1,2,3,4 (Public) JPEGs
Board 4: Asset EXT-C.10 is the last column on that Table: Pairing with E-Series Volumes (first Column)
Website statistics on 9/22/2026 — all-time (public metrics)
- Views: 2,597,302
- Visitors: 1,625,151
- Posts: 6,300
- Pages 607
- Home Page: 52 Tab Pages of which 4 are Portals. They are not Posts in the Journal
- Projection of Article Views shows the rate of growth of Articles published in the Journal, 2012 to 2025
PharmaceuticalIntelligence.com Journal – Projecting the Annual Rate of Article Views
Also see
-
COM 23 Parent (pricing model).
Part 23: Pricing Model for Fair Value of Category B Assets in Z (Phase-2 Valuation Event) based on “interaction-type” and “prompt grid” Method
-
C-22 Part E (registry row).
Part E — Registry of Category B assets
-
Appendix C-SPA Schedule B = Yes.
Appendix C-SPA
Public Access is available to
- the following Composition of Methods Parts
- 2026 & Beyond LPBI Group Vision
- ALL articles published in the Journal N=6,300
TOOL FACTORY, Composition of Methods (COM), IP Asset Class IV
https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/
as well as to
2026 & BEYOND MASTER PLAN
https://pharmaceuticalintelligence.com/2026-beyond-master-plan/
This page has the following sub pages.
2012pharmaceutical
sjwilliamspa